Cardiovascular Products « Go Back
  • ATELOL
  • ATELOL-D
  • VASOGARD
  • VASOGARD - AT
  • Qualitative & Quantitative Composition.

    Each uncoated tablet contains Atenolol I.P. 25 mg / 50mg.
  • Dosage Form

    Oral Tablets
  • Therapeutic indications

    Anti hypertensive and anti anginal
  • Dosage and administration

    Atelol- 25
    High Blood Pressure
    25 mg tablets: the usual dose is two to four tablets, once a day.
    Angina
    25 mg tablets: the usual dose is four tablets once a day, or two tablets twice a day.
    Irregular heart beats
    25 mg tablets: the usual dose is two to four tablets, once a day.

    Atelol- 50
    High Blood Pressure
    50 mg tablets: the usual dose is one to two tablets, once a day.
    Angina
    50 mg tablets: the usual dose is two tablets once a day, or one tablets twice a day.
    Irregular heart beats
    50 mg tablets: the usual dose is one to two tablets, once a day.
    As directed by physician
  • Contra-indications

    Should not use if allergic to atenolol or any of the other ingredients in the product. Atenolol is contraindicated in sinus bradycardia, sinus node dysfunction, heart block >1st degree, compensated cardiac failure, cardiogenic shock, bronchospastic diseases, peripheral vascular diseases. Also contraindicated during pregnancy .
  • Warnings and Precautions

    While generally safe for use, but in case of compensated heart failure. Variant angina, acute MI, DM; peripheral vascular disorders; hepatic and renal dysfunction; elderly patients, children. and during lactation precaution is needed.
  • Drug interactions

    Decreased effect with aluminum and calcium salts, barbiturates, cholestyramine, NSAIDs, ampicillin,rifampicin.
  • Pregnancy & lactation

    Category D.
  • Undesirable effects/side effects

    Like many medicines, Atenolol may occasionally cause some unwanted effects. These are normally mild. Atenolol Tablets may occasionally produce drowsiness, dizziness, light-headedness, and blurred vision. There may be coldness of the hands and feet, tired muscles, or rarely, slowed heartbeats or sleep disturbances. Atenolol can cause dry mouth, nausea and vomiting, diarrhoea, constipation and abdominal cramps. Skin rashes and/or dry eyes have also been reported with Atenolol.
  • Overdose

    According to toxixity studies, the most important signs to be expected following acute overdose of atenolol are lethargy, sinus pause, bradycardia, hypotension, bronchospasm and/or hypoglycaemia.
  • Qualitative & Quantitative Composition.

    Each uncoated tablet contains Atenolol I.P. 50mg and Indapamide I.P. 2.5mg
  • Dosage Form

    Oral Tablets
  • Therapeutic indications

    Anti hypertensive and anti anginal
  • Dosage and administration

    1 tablet once daily.
    As directed by physician
  • Contra-indications

    Should not use if allergic to atenolol or indapamide or any of the other ingredients in the product. Atelol-D is contraindicated in sinus bradycardia, sinus node dysfunction, heart block > 1st degree, compensated cardiac failure, cardiogenic shock, bronchospastic diseases, peripheral vascular diseases, anuria, severe hepatic impairment. Also contraindicated during pregnancy .
  • Warnings and Precautions

    While generally safe for use, but in case of compensated heart failure. variant angina, acute MI, DM; peripheral vascular disorders; hepatic and renal dysfunction; elderly patients, children, pregnancy, lactation, fluid or electrolyte imbalance, hyperuricaemia, and lupus erythematosus.
  • Drug interactions

    Decreased effect with aluminum and calcium salts, barbiturates, cholestyramine, NSAIDs, ampicillin,rifampicin. Additive effect with other antihypertensive agents and diuretics. Increased chance of hypokalaemia with corticosteroids, corticotropin and amphotericin. Potentially Fatal: Increased risk of lithium toxicity. Hypokalaemia enhances digitalis toxicity with cardiac gycosides.
  • Pregnancy & lactation

    Category D.
  • Undesirable effects/side effects

    Drowsiness, dizziness, light-headedness, blurred vision, coldness of the hands and feet, tired muscles, slowed heartbeats, sleep disturbances, dry mouth, nausea and vomiting, diarrhoea, constipation and abdominal cramps, skin rashes and/or dry eyes, weakness, fatigue, agitation, nervousness, anorexia, orthostatic hypotension, palpitations, hypokalaemia, hyponatraemia, and metabolic alkalosis.
  • Overdose

    According to toxixity studies, the most important signs to be expected following acute overdose of Atelol-D are lethargy, sinus pause, bradycardia, hypotension, bronchospasm, hypoglycaemia, nausea, vomiting, weakness, GI disorders, and electrolyte imbalance.
  • Qualitative & Quantitative Composition.

    Each uncoated tablet contains Amlodipine Besilate I.P. equivalent to Amlodipine 5.0 mg .
  • Dosage Form

    Oral Tablets
  • Therapeutic indications

    Anti hypertensive and anti anginal
  • Dosage and administration

    Adult recommended starting dose: 1 Tablet once daily with maximum dose 2 Tablets once daily.
    Small, fragile, or elderly patients or patients with hepatic insufficiency may be started on 2.5 mg once daily.
    Pediatric starting dose: 2.5 mg to 5 mg once daily.
    Important Limitation: Doses in excess of 5 mg daily have not been studied in pediatric patients.
    As directed by physician
  • Contra-indications

    Known sensitivity to Amlodipine.
  • Warnings and Precautions

    Symptomatic hypotension is possible, particularly in patients with severe aortic stenosis. However, because of the gradual onset of action, acute hypotension is unlikely.
    Worsening angina and acute myocardial infarction can develop after starting or increasing the dose of amlodipine, particularly in patients with severe obstructive coronary artery disease.
    Titrate slowly when administering calcium channel blockers to patients with severe hepatic impairment.
  • Drug interactions

    If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin
  • Pregnancy & lactation

    Category C.
  • Undesirable effects/side effects

    Most common adverse reactions are headache and edema which occurred in a dose related manner. Other adverse experiences not dose related but reported with an incidence >1% are headache, fatigue, nausea, abdominal pain, and somnolence.
  • Overdose

    Overdosage might be expected to cause excessive peripheral vasodilation with marked hypotension and possibly a reflex tachycardia. In humans, experience with intentional overdosage of amlodipine is limited.
  • Qualitative & Quantitative Composition.

    Each uncoated tablet contains Amlodipine Besilate I.P. equivalent to Amlodipine 5.0 mg and Atenolol I.P. 50mg.
  • Dosage Form

    Oral Tablets
  • Therapeutic indications

    Anti hypertensive and anti anginal
  • Dosage and administration

    1 tab once daily, may increase to 2 tablets daily if needed.
    As directed by physician
  • Contra-indications

    Hypotension, sinus bradycardia, 2nd & 3rd degrees of heart block, cardiogenic shock, overt congestive failure, poor LV function, hypersensitivity to either component, pregnancy.
  • Warnings and Precautions

    Excessive fall of BP may occur in elderly patients. Caution in patients with COPD, thyrotoxicosis, congestive failure, vasospastic angina, hepatic & renal impairment. Caution in diabetic patients as beta-blockers may mask tachycardia occurring with hypoglycaemia. Withdrawal should be gradual. Lactation. Safety and efficacy have not been established in children. Not to be used in untreated phaeochromocytoma.
  • Drug interactions

    Additive effect when used with catecholamine depleting drugs; monitor for hypotension and/or marked bradycardia. If used with clonidine, clonidine withdrawal should occur a few days after withdrawal of the beta-blocker to prevent rebound hypertension; if replacing clonidine by beta-blocker, beta-blocker should be introduced only after clonidine administration has stopped for several days. Concurrent use with prostaglandin synthase inhibiting drugs (e.g. indomethacin) may reduce the hypotensive effects of beta-blockers.
  • Pregnancy & lactation

    Category D.
  • Undesirable effects/side effects

    Headache, hypotension, dizziness, breathlessness, fatigue, muscle cramps, bradycardia, palpitations, flushing, oedema, dyspnoea, dyspepsia, cold extremities. Drowsiness, chestpain & impotence rarely. Hypersensitivity reactions.
  • Overdose

    Overdosage may cause hypotension and less commonly, congestive cardiac failure. Unabsorbed drug may be removed by gastric lavage or use of activated charcoal. Symptomatic treatment may be administered.